Sector revisions Bristol-Myers Squibb Company

Equities

Real-time Estimate Cboe BZX Other stock markets 16:18:01 22/01/2026 GMT			5-day change	1st Jan Change
55.18 ^USD	+1.26%		-2.37%	+2.48%

02:22pm	Sector Update: Health Care Stocks Mixed Pre-Bell Thursday	MT
12:50pm	Bristol-Myers Squibb, Janux Therapeutics Sign Deal to Develop Cancer Drug	MT

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	BRISTOL-MYERS SQUIBB COMPANY							23
	ELI LILLY AND COMPANY							28
	JOHNSON & JOHNSON							24
	ABBVIE INC.							27
	ROCHE HOLDING AG							19
	ASTRAZENECA PLC							20
	NOVARTIS AG							20
	MERCK & CO., INC.							27
	NOVO NORDISK A/S							21
	AMGEN INC.							27
	GILEAD SCIENCES, INC.							26
	PFIZER INC.							24
	VERTEX PHARMACEUTICALS INCORPORATED							25
	SANOFI							22
	GSK PLC							19
	CHUGAI PHARMACEUTICAL CO., LTD.							14
	JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD							17
	TAKEDA PHARMACEUTICAL COMPANY LIMITED							15
	BAYER AG							20
	Average							22
	Weighted average by Cap.							24